Eli Lilly: Medicare to Fully Cover Alzheimer’s Drugs

Published on April 21, 2023

The fight against Alzheimer’s disease is like an intense game of chess. Eli Lilly and Co, a major player in the healthcare industry, believes that Medicare, the U.S. health plan, will soon change its strict coverage limits on new Alzheimer’s drugs. This exciting development comes as more evidence mounts on the effectiveness of these medications in clearing amyloid brain plaques and improving patients’ condition. Just like making strategic moves on the chessboard, Lilly plans to provide additional data to support their case. By doing so, they hope to convince Medicare that expanding coverage for Alzheimer’s drugs is necessary and beneficial for patients. If successful, this decision could have a significant impact on individuals suffering from this devastating disease and their access to potentially life-changing treatments. To delve deeper into the ongoing research and advancements in Alzheimer’s treatment, it’s worth exploring the linked article!

Eli Lilly and Co expects the U.S. Medicare health plan to back down from strict coverage limits on new Alzheimer’s drugs as more evidence emerges in coming weeks showing that clearing amyloid brain plaques can help patients, a company executive told Reuters. Lilly plans to…

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>